Alpenglow Biosciences® is hosting a lunch event on September 10th featuring Dr. Sandra Schuh presenting her latest work using 3D imaging technologies.
Published
Signal category
Presence & Recognition
Quote
“Join us for lunch on September 10th, where Dr. Schuh will present her latests work using 3D imaging technologies.”
— Steve Pemberton|Alpenglow Biosciences® team
Company
Alpenglow Biosciences®
3D tissue imaging data for spatial biology
- Industry
- Biotechnology Research
- Location
- Seattle, US
- Company size
- 32 employees
Alpenglow Biosciences accelerates drug development and improves clinical diagnostics with light-sheet 3D tissue imaging and AI-powered analysis for spatial biology and digital pathology. The Aurora 3D spatial biology platform digitizes intact tissue samples, delivering quantitative 3D datasets while preserving tissue for molecular analysis Partners use Alpenglow Biosciences to: - Discover new biology in intact tissue - Generate analysis-ready volumetric datasets and spatial metrics - Support AI model development with ground truth 3D data - Improve decision-making in preclinical and clinical programs Five of the top 10 pharmaceutical companies collaborate with Alpenglow to uncover new insights, streamline timelines, and improve success rates across their pipelines. We are hiring talented individuals for roles in business development, wet lab, hardware, and software.
Founded 2018